These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6866728)

  • 1. Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal species.
    Chatelain P; Robberecht P; Waelbroeck M; De Neef P; Camus JC; Huu AN; Roba J; Christophe J
    Pflugers Arch; 1983 Apr; 397(2):100-5. PubMed ID: 6866728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J; Waelbroeck M; Chatelain P; Robberecht P
    Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat.
    Chatelain P; Robberecht P; De Neef P; Camus JC; Poloczek P; Christophe J
    Pflugers Arch; 1981 Apr; 390(1):10-6. PubMed ID: 6264381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide stimulation of renal adenylate cyclase and antagonism by (4Cl-D-Phe6Leu17)VIP.
    Griffiths NM; Simmons NL; Rivier J
    Pflugers Arch; 1989 Jun; 414(2):222-7. PubMed ID: 2755776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretin and VIP-stimulated adenylate cyclase from rat heart. I. General properties and structural requirements for enzyme activation.
    Chatelain P; Robberecht P; De Neef P; Deschodt-Lanckman M; König W; Christophe J
    Pflugers Arch; 1980 Dec; 389(1):21-7. PubMed ID: 7193463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretin and VIP-stimulated adenylate cyclase from rat heart. II. Impairment in spontaneous hypertension.
    Chatelain P; Robberecht P; De Neef P; Camus JC; Heuse D; Christophe J
    Pflugers Arch; 1980 Dec; 389(1):29-35. PubMed ID: 7193464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung.
    Taton G; Delhaye M; Camus JC; de Neef P; Chatelain P; Robberecht P; Christophe J
    Pflugers Arch; 1981 Sep; 391(3):178-82. PubMed ID: 6126856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
    Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of secretin and vasoactive intestinal peptide receptors in rat pancreatic plasma membranes using the native peptides, secretin-(7-27) and five secretin analogues.
    Robberecht P; Waelbroeck M; Noyer M; Chatelain P; De Neef P; König W; Christophe J
    Digestion; 1982; 23(3):201-10. PubMed ID: 6286393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive rats.
    Robberecht P; Gillet L; Chatelain P; De Neef P; Camus JC; Vincent M; Sassard J; Christophe J
    Peptides; 1984; 5(2):355-8. PubMed ID: 6473161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of retinal adenylate cyclase by vasoactive intestinal peptide (VIP).
    Longshore MA; Makman MH
    Eur J Pharmacol; 1981 Mar; 70(2):237-40. PubMed ID: 7262187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of secretin-stimulated cardiac adenylate cyclase activity in rats with portacaval shunt.
    De Fontaine S; Robberecht P; De Neef P; Christophe J
    Peptides; 1986; 7(4):645-9. PubMed ID: 3763438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
    Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
    Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J
    Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes.
    Taton G; Chatelain P; Delhaye M; Camus JC; De Neef P; Waelbroeck M; Tatemoto K; Robberecht P; Christophe J
    Peptides; 1982; 3(6):897-900. PubMed ID: 6897744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adenylate cyclase activity in heart membranes from normotensive and spontaneously hypertensive rats, after chemical sympathectomy, suggests the presence of presynaptic secretin receptors.
    Chatelain P; Robberecht P; Camus JC; De Neef P; Waelbroeck M; Roba J; Christophe J
    Eur J Pharmacol; 1983 Sep; 93(3-4):271-6. PubMed ID: 6315454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate cyclase stimulation by VIP in rat and human parotid membranes.
    van Bogaert P; Soukias Y; Dehaye JP; Lambert M; Poloczek P; Winand J; Mayer R; Christophe J
    Regul Pept; 1987 Jun; 17(6):339-48. PubMed ID: 3602475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early decrease in secretin-, glucagon-, and isoproterenol-stimulated cardiac adenylate cyclase activity in rats treated with isoproterenol.
    Chatelain P; Robberecht P; De Neef P; Camus JC; Christophe J
    Biochem Pharmacol; 1982 Feb; 31(3):347-52. PubMed ID: 6280726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria.
    Robberecht P; De Neef P; Waelbroeck M; Camus JC; Fontaine J; Christophe J
    Pflugers Arch; 1984 May; 401(1):1-5. PubMed ID: 6540864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.